Built as the first commercially available scanner to deliver truly digital PET, the Vereos PET/CT, from Philips, offers revolutionary Digital Photon Counting technology. The science behind this scanner evolution is ‘quite complicated’, agrees Piotr Maniawski, Director of Clinical Science Nuclear Medicine at Philips Healthcare, yet the improved performance is significant, particularly when…
With the help of a new radioactive tracer, doctors can predict with more than 80 percent accuracy how well a widely-used lung cancer drug will combat tumors, according to researchers at Stanford. The researchers developed a PET scan-compatible imaging agent engineered to seek out a specific mutation found in nonsmall cell lung cancer (which accounts for about 80 percent of lung cancers), bind to…
The Clinica Creu Blanca Diagnostic Group in Barcelona, Spain, is the first clinic in Europe to use Canon Medical System’s new Celesteion PET-CT Scanner. Dr. Xavier Alomar, Head of the Diagnostic Imaging Department at the Clinic, explains how the new system has opened up a large field of diagnostic possibilities for the Group in Metabolic Medicine in Oncology, Neurology, Cardiology and…
Combining molecular information and high contrast resolution may well improve current performance in colorectal cancer (CRC) cases, according to Vicky Goh, who presented the latest results on PET/MRI during the last European Society of Medical Oncology (ESMO) meeting in Madrid PET/MRI brings the best of both modalities together: high contrast to noise and high spatial resolution combined with…
Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler AG, signed an agreement on the sale of its entire cyclotron division to Alliance Medical Ltd.
Bruker announced that it has signed an agreement to acquire the preclinical imaging business of Oncovision, a leading provider of innovative medical imaging devices used for the diagnosis of cancer. Financial terms of the agreement were not disclosed.
‘The combination of nuclear medicine and modern imaging procedures such as CT and MRI is becoming increasingly important in the diagnosis, treatment planning and aftercare of cancerous diseases,’ explains Professor Katrine Åhlström Riklund, who presides over the newly established European Society for Hybrid Medical Imaging, ESHI.
Head and neck cancer patients may no longer have to undergo invasive post-treatment surgery to remove remaining cancer cells, as research shows that innovative scanning-led surveillance can help identify the need for, and guidance of, neck dissection. The study from the Universities of Birmingham and Warwick and University Hospitals Coventry and Warwickshire used advanced imaging to identify…
Eckert & Ziegler AG, a specialist for isotope-based applications in medicine, science and industry, is expanding its cooperation program with promising drug developers in the field of nuclear medicine and will support Curasight, a spin-off based on research by the group of Professor Andreas Kjaer at the National University Hospital (Rigshospitalet) and University of Copenhagen, in obtaining…
The European Society of Radiology (ESR) is proud to announce the foundation of a new subspecialty society, the European Society for Hybrid Medical Imaging (ESHI).
PET/MR has long been studied for oncology but the technique also holds promise in cardiovascular applications, according to a panel of experts at the recent International Conference on Nuclear Cardiology and Cardiac CT (ICNCT).
Researchers at Columbia University have reported a new approach to visualize glucose uptake activity in single living cells by light microscopy with minimum disturbance.
Dr Gerald Antoch, professor of radiology and chairman of the department of diagnostic and interventional radiology at Düsseldorf University Hospital and active member of several scientific societies, delivered the prestigious Wilhelm Conrad Röntgen Honorary Lecture at ECR 2015 on ‘Hybrid imaging: Let the two worlds of radiology and nuclear medicine come together’. Report: Marcel Rasch
The importance of cardiac imaging is increasing, but nuclear medicine procedures are by no means obsolete, observes Okan Ekinci, during our EH interview with the Siemens Vice President for Healthcare Consulting & Clinical Affairs about the latest innovations for cardiology.
Before 2013, when Professor Dietmar Dinter became partner of Radiologie Schwetzingen, a multi-discipline group practice specialised in radiology and nuclear medicine, he was senior resident at the Institute of Clinical Radiology and Nuclear Medicine at University Hospital Mannheim (2003-2012) and head of its Nuclear Medicine Department (2009-2012). Was his work in nuclear medicine altered by the…
What's the ideal solution for vulnerable plaque imaging? 'A non-invasive imaging procedure with high spatial and temporal resolution, and without radiation exposure, and which provides information on coronary plaque composition precisely and in series.' Report: Axel Viola
The significant benefits of cardiac catherisation remain undisputed. However, cross-sectional imaging modalities are serious competitors when it comes to arriving at the right diagnosis.
A session at the forthcoming British Cardiovascular Society annual conference (2-4 June, in Manchester) will hear about the latest imaging techniques for acquired heart disease, with PET technology playing a key role in those advances.
Claron Technology, the leader in universal medical imaging viewers, announces that it has been awarded the CE mark for its NilRead zero-footprint viewer for the diagnostic interpretation of medical images.
US-American researchers have shown that positron emission tomography (PET), a tried procedure, is a helpful modality to detect breast cancer.
However, investments in equipment and advanced training are attracting medical students, John Brosky reports
European Hospital met up with Professor Harald H. Quick, PhD, who was appointed Director of the Erwin L. Hahn Institute (ELH) for Magnetic Resonance (MR) Imaging this February.
The multiple benefits of PET/CT are undisputed – one being the fact that radiopharmaceuticals, which are used at pico and nano levels – are not toxic.
Screening for lung cancer saves lives. This fact has been documented by outcomes of the U.S. National Lung Screening Trial (NLST) which showed a 20% reduction in lung cancer-specific deaths in patients who had a chest CT screening. What is controversial is how to establish the radiology resources needed to perform exams for all the people who need it and then how to pay for the exams.
With MRI and CT scanners widely available in clinical routine, radiologists cull increasingly precise and relevant functional tumour information for diagnostics and monitoring purposes. Both modalities offer technological and methodological approaches, initiated by the discipline itself, that have become indispensable for certain frequent tumours.